Leo Furcht - Nov 28, 2023 Form 4 Insider Report for Celcuity Inc. (CELC)

Role
Director
Signature
/s/ Eric O. Madson as Attorney-in-Fact for Leo Furcht pursuant to Power of Attorney previously filed.
Stock symbol
CELC
Transactions as of
Nov 28, 2023
Transactions value $
$400
Form type
4
Date filed
11/30/2023, 04:12 PM
Previous filing
May 24, 2023
Next filing
Jun 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CELC Common Stock Options Exercise $400 +250 +2.44% $1.60 10.5K Nov 28, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CELC Stock Option (right to buy) Options Exercise $0 -250 -100% $0.00* 0 Nov 28, 2023 Common Stock 250 $1.60 Direct F1
holding CELC Stock Option (right to buy) 250 Nov 28, 2023 Common Stock 250 $3.60 Direct F1
holding CELC Stock Option (right to buy) 250 Nov 28, 2023 Common Stock 250 $7.60 Direct F1
holding CELC Stock Option (right to buy) 250 Nov 28, 2023 Common Stock 250 $7.60 Direct F1
holding CELC Stock Option (right to buy) 500 Nov 28, 2023 Common Stock 500 $5.50 Direct F1
holding CELC Stock Option (right to buy) 500 Nov 28, 2023 Common Stock 500 $5.50 Direct F1
holding CELC Stock Option (right to buy) 5.05K Nov 28, 2023 Common Stock 5.05K $5.50 Direct F1
holding CELC Stock Option (right to buy) 25.3K Nov 28, 2023 Common Stock 25.3K $5.10 Direct F1
holding CELC Stock Option (right to buy) 4.62K Nov 28, 2023 Common Stock 4.62K $5.50 Direct F1
holding CELC Stock Option (right to buy) 24.4K Nov 28, 2023 Common Stock 24.4K $5.50 Direct F1
holding CELC Stock Option (right to buy) 11.6K Nov 28, 2023 Common Stock 11.6K $9.58 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully vested.
F2 This Option will vest and become exercisable on April 30, 2024, or if earlier, the date of the Company's 2024 Annual Meeting of Stockholders.